Clinical trials: Onabotulinum Toxin A
Transfer Dysphagia, Oropharyngeal Dysphagia
Onabotulinum Toxin A (Botox) in the Treatment of Pharyngo-esophageal Dysphagia
Dysphagia in patients with stroke, multiple sclerosis, parkinsonism or dystonia can occur due to relative hypertonia of the cricopharyngeus muscle. In the resting state, muscle is contracted and relaxes only during deglutition.
- Conditions
- Transfer Dysphagia, Oropharyngeal Dysphagia, Cricopharyngeus Muscle Dysfunction
- Trial name
- NCT04695600
- Testing
- Botulinum Toxin Type A Injection [Botox]
- Where
- India
- Volunteers
- 100 people
- Sponsor
- All India Institute of Medical Sciences
Cerebral Palsy, Cerebral Palsy, Spastic
Physiotherapy After Botulinum Toxin Injection and Serial Casting
The effects of different physiotherapy programs on children with cerebral palsy who have been received botulinum toxin injection and serial casting application will be determined.
- Trial name
- NCT05312125
- Testing
- backward downhill walking, routine physiotherapy
- Where
- Turkey (Türkiye)
- Volunteers
- 19 people
- Sponsor
- Gazi University